CIRBP is a novel oncogene in human bladder cancer inducing expression of HIF-1α

Cold-inducible RNA binding protein (CIRBP) has been reported to be associated with distinct tumorigenesis. In this study, we investigated the role of CIRBP in human bladder cancer (BCa), indicating that CIRBP is overexpressed in BCa tissues and cell lines to promote proliferation and migration. Moreover, CIRBP could induce expression of HIF-1α via binding to the 3′-UTR of its mRNA to increase the mRNA stability in BCa cells. Furthermore, we demonstrated that PTGIS is a HIF-1α targeted gene, a major regulator in hypoxic cancer progression by activating transcription of various oncogenes. Our results also suggested that overexpression of HIF-1α may suppress the expression of PTGIS in BCa cells, by binding to HRE sequence at the promoter region of PTGIS. In addition, we found a strongly downregulation of PTGIS in BCa tissue and transcriptionally inhibited by HIF-1α in BCa cells, which could be triggered by its DNA methylation. Further result suggested that knockdown of CIRBP could promote the expression of PTGIS, meanwhile knockdown of PTGIS could partially rescue CIRBP-deficiency induced inhibition of migration and proliferation in BCa cells. Taken together, our study indicated that CIRBP could be a novel oncogene in human bladder cancer inducing transcription of HIF-1α, which could inhibit expression of methylated PTGIS.

[1]  R. Conaway.  Faculty Opinions recommendation of FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[2]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[3]  M. Lleonart,et al.  A new generation of proto-oncogenes: cold-inducible RNA binding proteins. , 2010, Biochimica et biophysica acta.

[4]  V. Moreno,et al.  Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy , 2005, Oncogene.

[5]  A. Yemm,et al.  PERK/eIF2α signaling inhibits HIF-induced gene expression during the unfolded protein response via YB1-dependent regulation of HIF1α translation , 2018, Nucleic acids research.

[6]  F. Carrier,et al.  The UV-inducible RNA-binding Protein A18 (A18 hnRNP) Plays a Protective Role in the Genotoxic Stress Response* , 2001, The Journal of Biological Chemistry.

[7]  Wei Li,et al.  HIF-1α pathway: role, regulation and intervention for cancer therapy , 2015, Acta pharmaceutica Sinica. B.

[8]  A. Harris,et al.  Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.

[9]  G. Semenza,et al.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.

[10]  Jung Hur,et al.  Emerging roles of RNA and RNA-binding protein network in cancer cells. , 2009, BMB reports.

[11]  A. Harris,et al.  Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis , 2009, British Journal of Cancer.

[12]  Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer , 2015, Clinical Epigenetics.

[13]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[14]  Shiyong Wu,et al.  The mechanism of CIRP in inhibition of keratinocytes growth arrest and apoptosis following low dose UVB radiation , 2017, Molecular carcinogenesis.

[15]  Hae Na Lee,et al.  Cold-inducible RNA-binding protein promotes epithelial-mesenchymal transition by activating ERK and p38 pathways. , 2016, Biochemical and biophysical research communications.

[16]  David J Weber,et al.  Post-transcriptional regulation of thioredoxin by the stress inducible heterogenous ribonucleoprotein A18 , 2006, Nucleic acids research.

[17]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[18]  A. Lazaris,et al.  Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. , 2004, European urology.

[19]  J. Pouysségur,et al.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.

[20]  A. Bird,et al.  Effects of DNA methylation on DNA-binding proteins and gene expression. , 1993, Current opinion in genetics & development.

[21]  T. Willson,et al.  Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  V. Ullrich,et al.  Colocalization prostacyclin (PGI2) synthase--caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. , 2001, Experimental cell research.

[23]  T. Shiozawa,et al.  Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF‐1α to a hypoxia‐induced, methylation‐free hypoxia response element of S100A4 gene , 2012, International journal of cancer.

[24]  V. Mauro,et al.  A 5′ Leader of Rbm3, a Cold Stress-induced mRNA, Mediates Internal Initiation of Translation with Increased Efficiency under Conditions of Mild Hypothermia* , 2001, The Journal of Biological Chemistry.

[25]  R. Kirschner,et al.  Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism , 2004, Journal of Cell Science.

[26]  Y. Miller,et al.  Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. , 2002, Cancer research.

[27]  M. Schindl,et al.  Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  K. O'Byrne,et al.  The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. , 2010, Biochimica et biophysica acta.

[29]  Weiqing Wang,et al.  Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway , 2016, Oncotarget.

[30]  Teppei Shimamura,et al.  Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A , 2012, Molecular and Cellular Biology.

[31]  I. Leav,et al.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. , 2010, Cancer cell.

[32]  Ko-Fan Chen,et al.  Transcriptional repression of human cad gene by hypoxia inducible factor-1α , 2005, Nucleic acids research.

[33]  G. Semenza,et al.  Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. , 2014, Annual review of pathology.

[34]  Wei Jiang,et al.  Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway , 2016, Scientific Reports.

[35]  D. Peet,et al.  FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. , 2002, Genes & development.

[36]  Yair Lotan,et al.  Bladder cancer , 2020, Nature Reviews Disease Primers.

[37]  S. Batra,et al.  Expression of MUC17 Is Regulated by HIF1α-Mediated Hypoxic Responses and Requires a Methylation-Free Hypoxia Responsible Element in Pancreatic Cancer , 2012, PloS one.

[38]  G. Semenza,et al.  FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. , 2001 .

[39]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.

[40]  Qingyuan Yang,et al.  Heterogenous ribonucleoprotein A18 (hnRNP A18) promotes tumor growth by increasing protein translation of selected transcripts in cancer cells , 2016, Oncotarget.

[41]  V. Kolosov,et al.  Cold-inducible RNA-binding protein mediates airway inflammation and mucus hypersecretion through a post-transcriptional regulatory mechanism under cold stress. , 2016, The international journal of biochemistry & cell biology.

[42]  C. Logsdon,et al.  Silencing of the Hypoxia-Inducible Cell Death Protein BNIP3 in Pancreatic Cancer , 2004, Cancer Research.

[43]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[44]  G. Semenza.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. , 2012, Trends in pharmacological sciences.

[45]  M. Kudo,et al.  Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer. , 2014, Cancer research.

[46]  E. Nishida,et al.  ERK MAP kinase in G1 cell cycle progression and cancer , 2006, Cancer science.

[47]  Z. Meng,et al.  Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway , 2016, Oncotarget.

[48]  M. Gorospe,et al.  Increased stability of the p16 mRNA with replicative senescence , 2005, EMBO reports.

[49]  M. Zhan,et al.  Functional Significance for a Heterogenous Ribonucleoprotein A18 Signature RNA Motif in the 3′-Untranslated Region of Ataxia Telangiectasia Mutated and Rad3-related (ATR) Transcript* , 2010, The Journal of Biological Chemistry.

[50]  L. Ellis,et al.  Functional significance of vascular endothelial growth factor receptors on gastrointestinal cancer cells , 2007, Cancer and Metastasis Reviews.

[51]  M. Serrano,et al.  Cold-Inducible RNA-Binding Protein Bypasses Replicative Senescence in Primary Cells through Extracellular Signal-Regulated Kinase 1 and 2 Activation , 2009, Molecular and Cellular Biology.

[52]  U. Lendahl,et al.  Generating specificity and diversity in the transcriptional response to hypoxia , 2009, Nature Reviews Genetics.

[53]  Katsuhiko Itoh,et al.  A Glycine-rich RNA-binding Protein Mediating Cold-inducible Suppression of Mammalian Cell Growth , 1997, The Journal of cell biology.

[54]  G. Semenza,et al.  Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. , 2006, Cancer research.

[55]  P. Sorensen,et al.  Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis. , 2015, Cancer cell.

[56]  M. Kudo,et al.  Cold-inducible RNA-binding protein promotes the development of liver cancer , 2015, Cancer science.

[57]  S. Frede,et al.  Hypoxia‐induced erythropoietin expression in human neuroblastoma requires a methylation free HIF‐1 binding site , 2004, Journal of cellular biochemistry.